Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surfactant: clinical applications.

C D Patton1, E S Schulman

  • 1Hahnemann University School of Medicine, Philadelphia, Pennsylvania.

American Family Physician
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Preoperative Transophthalmic Artery Embolization of Meningiomas: A Systematic Review with a Focus on Embolization Agent.

AJNR. American journal of neuroradiology·2023
Same author

Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.

American journal of respiratory and critical care medicine·2001
Same author

Degranulation influences heparin-associated inhibition of RT-PCR in human lung mast cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2001
Same author

Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.

The Journal of allergy and clinical immunology·2001
Same author

Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation.

Free radical biology & medicine·2000
Same author

ATP modulates anti-IgE-induced release of histamine from human lung mast cells.

American journal of respiratory cell and molecular biology·1999
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Pulmonary surfactant therapy is crucial for premature infants with respiratory distress syndrome. It stabilizes alveoli, prevents edema, and is administered via endotracheal tube for optimal outcomes.

Area of Science:

  • Pulmonary medicine
  • Biochemistry

Background:

  • Pulmonary surfactant is a vital lung component.
  • It reduces alveolar surface tension, stabilizing lung function and potentially preventing pulmonary edema.

Purpose of the Study:

  • To outline the therapeutic use of pulmonary surfactant.
  • To detail its application in neonatal respiratory distress syndrome (RDS).

Main Methods:

  • Surfactant administration via endotracheal tube.
  • Recommended dosage: 5 mg per kg.
  • Prophylactic therapy: Three doses, 12 hours apart.
  • Rescue therapy: Two doses, 12 hours apart.

Main Results:

  • Pulmonary surfactant is effective in treating neonatal RDS.

Related Experiment Videos

  • It is recommended for both prophylactic and rescue therapy in premature infants.

    • Conclusions:

    • Surfactant therapy is a key intervention for premature infants with RDS.
    • Specific dosing and administration protocols ensure optimal therapeutic benefits.